sábado, 10 de junio de 2023

PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia

https://www.news-medical.net/news/20230609/PREACH-M-trial-Lenzilumab-may-improve-treatment-response-in-chronic-myelomonocytic-leukemia.aspx

No hay comentarios: